TrialStudy to Evaluate Sex Differences in the Acute Effects of PL-3994 in Heart Failure Subjects
Trial details
- Registry ID
- NCT04318145
- Phase
- Phase 2
PTN
Palatin Technologies, Inc
Company identity checked against sources
Browse linked trials and recorded changes, or follow this company for updates.
5Trials in this database
5Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far
Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.
Completion dates · Pro
Which trial dates moved later?
Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features
Included trials
Check company identity source| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study to Evaluate Sex Differences in the Acute Effects of PL-3994 in Heart Failure SubjectsNCT04318145 | PTN | Phase 2 | Terminated | 2023-12-08Actual |
| A Phase 3, Multi-Center Study Evaluating PL9643 in Patients with Dry EyeNCT05201170 | PTN | Phase 3 | Completed | 2023-09-01Actual |
| Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)NCT05466890 | PTN | Phase 2 | Active not recruiting | 2025-02-10Actual |
| A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney DiseaseNCT05709444 | PTN | Phase 2 | Completed | 2024-04-26Actual |
| A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of ObesityNCT06565611 | PTN | Phase 2 | Active not recruiting | 2025-02-05Actual |
A Phase 3, Multi-Center Study Evaluating PL9643 in Patients with Dry Eye
Trial details
- Registry ID
- NCT05201170
- Phase
- Phase 3
Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)
Trial details
- Registry ID
- NCT05466890
- Phase
- Phase 2
A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease
Trial details
- Registry ID
- NCT05709444
- Phase
- Phase 2
A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity
Trial details
- Registry ID
- NCT06565611
- Phase
- Phase 2
Latest recorded trial changes
Study to Evaluate Sex Differences in the Acute Effects of PL-3994 in Heart Failure Subjects
NCT04318145 · Palatin Technologies, Inc
Participant count type changed
− Before
Estimated
+ After
Actual
Enrollment · participant count changed
− Before
55 participants (planned)
+ After
15 participants (actual)
Completion date type changed
− Before
Estimated
+ After
Actual
Primary completion date changed
− Before
31 Mar 2022
+ After
8 Dec 2023
Recruitment status changed
− Before
Recruiting
+ After
Terminated